Design and Immunogenicity of SARS-CoV-2 DNA vaccine encoding RBD-PVXCP fusion protein
D. Dormeshkin, M. Katsin, M. Stegantseva, S. Golenchenko, M. Shapira, S. Dubovik, D. Lutskovich, A. Kavaleuski, A. Meleshko
This paper develops a DNA vaccine encoding RBD-PVXCP fusion protein that induces strong antibody and cellular responses against SARS-CoV-2 variants in mice and rabbits.
bioRxiv · Oct 6, 2022 · PreprintImmunology